39.86500 EUR
64.795
61.91%
Last update Dec 15, 5:25 PM CET
Market closed
Day range
39.82000
102.18000
Previous close
104.66000
Open
39.82000
Access this stock data via API
Subscribe
Gilead Sciences Inc.
39.87
64.80
61.91%

Overview

Access /time_series data via our API — starting from the Basic plan.

Description

Gilead Sciences Inc. is a biopharmaceutical company that focuses on researching, developing, and commercializing innovative medicines in areas of unmet medical need. It is globally recognized for its distinguished work, particularly in the treatment of HIV, liver diseases such as hepatitis B and C, and various forms of cancer. The company's portfolio includes groundbreaking antiviral therapies and a robust pipeline of investigational drugs. Headquartered in Foster City, California, Gilead Sciences Inc. significantly contributes to the healthcare sector by extending the lives of patients with serious illnesses worldwide. Through strategic partnerships and continuous innovation, Gilead remains at the forefront of modern medicine, enhancing its role in the global pharmaceutical market.

About

CEO
Mr. Daniel P. O'Day
Employees
17600
Address
333 Lakeside Drive
Foster City, 94404, CA
United States
Phone
650 574 3000
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Drug Manufacturers - General
Country
Germany
MIC code
XFRA
Access /profile data via our API — starting from the Grow plan.
Market closed

Exchange is currently closed
Main market opens in 1 hour 18 minutes

06:41
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).